BIO represents pioneers in the world’s most innovative industry. It’s our job to support and advocate for our members as they pursue cutting-edge scientific and technological advancements — from finding new ways to treat cancer to enhancing the very food we eat to creating a sustainable environment…

Dr. Gregory Dolin of the Center for Medicine and Law at the University of Baltimore School of Law shared his objections to legislative proposals that falsely link drug costs with patents in an op-ed that ran in The Washington Times this week. As Dolin states, current legislative proposals would…

Dr. Akshaya Shanmugam has always believed that healthcare should be accessible and affordable to everyone and that technology can help deliver that promise. With her strong background in biomedical engineering, she decided to take on a problem facing over 200 million people in the US: addiction. In…

Fighting for diversity in the workplace is more than a “feel good” or “the right thing to do” proposition. Indeed, an environment of inclusion often broadens the talent pool and perspective of companies which, in turn, can make those companies more successful. Today we celebrate International Women…

Across the United States, farmers use biotech crops to address production challenges – such as pests, disease, and extreme weather – and improve the productivity and health of their plants. However, American farmers planting such crops are often unable to access the Chinese market and export…

The labeling of our food has been a conversation for several decades. Whether it’s nutritional facts, ingredient lists, marketing claims, or how appealing one label looks over another, food labels are of interest to almost everyone. Lately the conversation around food labels has moved from…

Here’s a statistic you might not have known: an estimated 700,000 people die each year due to the growing number of infections resistant to treatment. Known as antimicrobial resistance (AMR), this “silent killer” and looming public health threat has severe social and economic consequences that…

Despite considerable pressure directed squarely at biotech innovators from politicians of every stripe, biotech executives remained focused on finding the medicines of tomorrow at the BIO CEO & Investor Conference. New York, host of the event for the past 21 years, continues to be a premier…

Biotech startups come in all shapes, sizes and approaches but have one thing in common: the drive to develop technology that will address a high unmet need and improve patients’ lives.  Nancy Thornberry, the current CEO of Kallyope Inc., didn’t always work for startups, but she has spent a…

New medicines often progress from idea to regulatory approval through collaborative licensing agreements or acquisition.  Deal-making has become one of the most critical skills for a biotech’s leadership team in developing products to improve patients’ lives.  On February 10 BIO will…